CNS pipeline · person
Eric Green, MBA
Chief Operating Officer of Seaport Therapeutics. Previously SVP and Head of Development Programs at Alnylam Pharmaceuticals, where he led the global approval of ONPATTRO (patisiran, the first approved RNAi therapeutic), with prior experience at Synageva, Infinity, Genzyme and Pfizer.
- 1 company
Current roles
- Seaport Therapeutics, Inc.Chief Operating Officer · Executive
Appears with
People sharing a company with Eric.
- Antony Loebel · Seaport Therapeutics, Inc.
- Bob Hombach · Seaport Therapeutics, Inc.
- Daphne Zohar · Seaport Therapeutics, Inc.
- David Wheadon · Seaport Therapeutics, Inc.
- Denice Torres · Seaport Therapeutics, Inc.
- Jason Pitts · Seaport Therapeutics, Inc.
- Jim Healy · Seaport Therapeutics, Inc.
- Lana Gladstein · Seaport Therapeutics, Inc.
- Lauren White · Seaport Therapeutics, Inc.
- Michael Chen · Seaport Therapeutics, Inc.
- Sandi Peterson · Seaport Therapeutics, Inc.
- Sharon Mates · Seaport Therapeutics, Inc.
- Steven Paul · Seaport Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.